Of interest, it has recently been shown that the MET receptor activating phosphorylation site was highly responsive to EGFRvIII levels in glioblastoma cells in vitro, suggesting downstream cross-activation of MET by mutant EGFRvIII (Huang et al, 2007). This evidence concerns the gene MET and glioblastoma.